Contribution of ergometry to the diagnosis of ischaemic heart disease
Hloucal, L.; Kálal, J.
Casopis Lekaru Ceskych 114(40): 1230-1236
1975
ISSN/ISBN: 0008-7335 PMID: 1182755 Document Number: 88230
Document emailed within 1 workday
Related Documents
Janousek, S.; Janda, I.; Simek, P.; Rotrekl, P.; Horák, Z. 1997: Thallium perfusion scintigraphy and bicycle ergometry in the diagnosis of ischemic heart disease. Comparison with coronarography findings Vnitrni Lekarstvi 43(12): 790-794Bahal, V.K.; Gupta, R.; Balachander, J.; Khalilullah, M. 1983: Stress testing for the diagnosis of ischaemic heart disease Journal of the Association of Physicians of India 31(11): 729-735
Riabykina, G.V.; Saltykova, M.M.; Sobolev, A.V. 1989: Diagnosis of ischaemic heart disease based on data of precordial mapping Cor et Vasa 31(6): 444-450
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605
Meurice, C.; Legrand, V.; Piérard, L. 2016: Contribution of Cardiac Catheterization to the Diagnosis and Treatment of Coronary Heart Disease before Age 40 Revue Medicale de Liege 71(3): 129-136
Golan, D.T.; Kursbaum, A. 1976: Anti-heart autoantibodies in ischaemic heart disease patients Clinical and Experimental Immunology 26(1): 86-90
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Piatak, O.A.; Lizogub, V.G.; Sen'ko, V.I. 1984: Indices of bulbar microcirculation and bicycle ergometry in patients with ischemic heart disease and neurocirculatory dystonia Vrachebnoe Delo 5: 77-80
Pech, H.J.; Parsi, R.A. 1986: Effect of slow-release ISDN on cardiac function in patients with coronary heart disease during bicycle ergometry Cor et Vasa 28(4): 257-265
Calvert, A.F.; Pater, G.; Pye, D.; Mann, J.; Chalmers, D.; Ayres, B. 1987: A matched pairs comparison of cycle ergometry and treadmill exercise testing in the evaluation of coronary heart disease Australian and New Zealand Journal of Medicine 17(5): 472-478
Bashir, R.; Khan, A.; Yousaf, M. 1996: Angiographically documented coronary artery disease in asymptomatic middle aged men suspected of silent ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 46(10): 225-228
Christie, J. 2011: Ischaemic heart disease prevention NursingTimes 107(30-31): 20
Wojtczak, A.; Skretkowicz, J. 2007: Genetics in ischaemic heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(133): 5-8
Constantine, G.R.; Thenabadu, P.N. 1996: Use of aspirin in ischaemic heart disease Ceylon Medical Journal 41(4): 167-168
Van Assche, F.A.; Aerts, L.; Holemans, K. 1994: Low birthweight and ischaemic heart disease Lancet 343(8899): 731-732
Law, M.R.; Wald, N.J. 1999: Homocysteine and ischaemic heart disease Haematologica 84 Suppl Eha-4: 57-60
Violi, F.; Iuliano, L.; Iullano, L. 1997: Antioxidants and ischaemic heart disease Lancet 350(9078): 667-668
Lhotka, J.; Stuchlíková, E.; Klimesová, A. 1971: Changes in the pericardium in ischaemic heart disease Acta Universitatis Carolinae. Medica 17(7): 573-580
Kucera, J. 1978: Congenital coronary artery defects and ischaemic disease of the myocardium. A population teratology contribution to the problem of myocardial infarction prevention Casopis Lekaru Ceskych 117(31): 945-949